Cancer Center, Dana-Farber, more receive $1.2M from family foundation

Cincinnati Business Courier highlights pediatric brain tumor research

The Cincinnati Business Courier highlighted a $1.2 million grant received by the University of Cincinnati Cancer Center's Timothy Phoenix and colleagues at Dana-Farber Cancer Institute and the German Cancer Research Center to study pediatric low-grade gliomas. 

Low-grade gliomas are one of the most common types of brain tumors and are associated with overall better survival outcomes, but these tumors and associated treatments still have a large impact on quality of life for kids, Phoenix said. 

“There’s been progress the past decade, and just last year there were multiple new drugs approved by the FDA that show efficacy and promise,” said Phoenix, PhD, a Cancer Center researcher and associate professor in UC’s James L. Winkle College of Pharmacy. “But we still don’t have a curative therapy for low-grade gliomas.” 

Using experience from developing models of pediatric high-grade gliomas, Phoenix and his colleagues will develop new models of pediatric low-grade gliomas to better understand their biology and growth patterns across brain development and maturation. 

“There’s really no good model for this disease, so we’ll be using our system to try to understand how these tumor cells interact with the normal brain during development and how that influences the start-and-stop growth pattern that they see in the clinic,” he said. “If we can improve and understand why this occurs and why after a certain age the chance of growth diminishes, then hopefully we can develop therapies that target these interactions.” 

Read the Cincinnati Business Courier article.

Read more about the research.

Featured photo at top of Phoenix working in his lab. Photo/Andrew Higley/UC Marketing + Brand.

 

Related Stories

1

Sugar overload killing hearts

November 10, 2025

Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.

2

Is going nuclear the solution to Ohio’s energy costs?

November 10, 2025

The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.

3

App turns smartwatch into detector of structural heart disease

November 10, 2025

An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.